P C Gupta1, P R Murti, R B Bhonsle, F S Mehta, J J Pindborg. 1. Basic Dental Research Unit and WHO Collaborating Centre for Oral Cancer Prevention, Tata Institute of Fundamental Research, Bombay, India.
Abstract
OBJECTIVE: To study the effect of cessation of tobacco use on the incidence of lichen planus, leukoplakia and other oral mucosal lesions. DESIGN: A 10-yr cohort study in a rural population of Ernakulam district, Kerala, India. MATERIAL AND METHODS: Some 12,212 tobacco users were interviewed and examined in a baseline survey and re-examined annually for 10 years. At each examination they were exposed to health educational programs to encourage them to quit their tobacco use. The incidence rates were calculated using person-years method among those who stopped their tobacco use and all others. RESULTS: A total of 77,681 person-years of observation accrued among men and 32,544 among women. Among men 6.5% of these and among women 14.4% were in the stopped category. The incidence of oral lichen planus did not show any consistent association with cessation of tobacco habits (incidence ratio 1.35) but for leukoplakia there was a substantial drop in the incidence after cessation (incidence ratio 0.31). Several other tobacco-associated oral mucosal lesions such as oral lichen planus-like lesion, smoker's palate, preleukoplakia, central papillary atrophy of the tongue and leukoedema showed either zero, or very small incidence, after cessation. CONCLUSION: The reported association between tobacco use and lichen planus appears to be indirect but for all other lesions it is direct. The cessation of tobacco use led to a substantial fall in the incidence of leukoplakia and other lesions implying a reduced risk for oral cancer after cessation of tobacco use.
OBJECTIVE: To study the effect of cessation of tobacco use on the incidence of lichen planus, leukoplakia and other oral mucosal lesions. DESIGN: A 10-yr cohort study in a rural population of Ernakulam district, Kerala, India. MATERIAL AND METHODS: Some 12,212 tobacco users were interviewed and examined in a baseline survey and re-examined annually for 10 years. At each examination they were exposed to health educational programs to encourage them to quit their tobacco use. The incidence rates were calculated using person-years method among those who stopped their tobacco use and all others. RESULTS: A total of 77,681 person-years of observation accrued among men and 32,544 among women. Among men 6.5% of these and among women 14.4% were in the stopped category. The incidence of oral lichen planus did not show any consistent association with cessation of tobacco habits (incidence ratio 1.35) but for leukoplakia there was a substantial drop in the incidence after cessation (incidence ratio 0.31). Several other tobacco-associated oral mucosal lesions such as oral lichen planus-like lesion, smoker's palate, preleukoplakia, central papillary atrophy of the tongue and leukoedema showed either zero, or very small incidence, after cessation. CONCLUSION: The reported association between tobacco use and lichen planus appears to be indirect but for all other lesions it is direct. The cessation of tobacco use led to a substantial fall in the incidence of leukoplakia and other lesions implying a reduced risk for oral cancer after cessation of tobacco use.
Authors: Daniela Russo; Francesco Merolla; Silvia Varricchio; Giovanni Salzano; Giovanni Zarrilli; Massimo Mascolo; Viviana Strazzullo; Rosa Maria Di Crescenzo; Angela Celetti; Gennaro Ilardi Journal: Biomed Rep Date: 2018-07-27
Authors: Andrew C Prince; Kristine E Day; Chee Paul Lin; Benjamin J Greene; William R Carroll Journal: Otolaryngol Head Neck Surg Date: 2018-06-05 Impact factor: 3.497
Authors: Jean-Philippe Foy; Chloé Bertolus; William N William; Pierre Saintigny Journal: Otolaryngol Clin North Am Date: 2013-05-25 Impact factor: 3.346
Authors: Eve M Nagler; Dhirendra N Sinha; Mangesh S Pednekar; Anne M Stoddard; Prakash C Gupta; Neha Mathur; Harry Lando; Mira Aghi; Laura Shulman Cordeira; K Viswanath; Glorian Sorensen Journal: Prev Med Date: 2015-02-02 Impact factor: 4.018